Bibliographic details
Pfeil AM, Kressig RW, Szucs TD. Alzheimer's dementia: budget impact and cost-utility analysis of a combination treatment with a cholinesterase inhibitor and memantine in Switzerland. Swiss Medical Weekly 2012; 142:w13676
MeSH
Adult; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease /drug therapy /economics; Cholinesterase Inhibitors /economics /therapeutic use; Cost-Benefit Analysis; Dopamine Agents /economics /therapeutic use; Drug Therapy, Combination; Fees, Pharmaceutical /statistics & Health Services /economics /utilization; Homes for the Aged /economics /utilization; Humans; Markov Chains; Memantine /economics /therapeutic use; Middle Aged; Models, Econometric; Nursing Homes /economics /utilization; Prevalence; Quality-Adjusted Life Years; Severity of Illness Index; Sex Factors; Switzerland; numerical data